N J Langford1, M J Kendall. Show Affiliations » 1. Clinical Pharmacology Section, Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK. n.j.langford@bham.ac.uk
Abstract
Entities: Disease Gene
Mesh： See more » Biological AvailabilityCholinergic Agents/adverse effectsCholinergic Agents/pharmacokineticsCytochrome P-450 Enzyme System/metabolismDrug InteractionsGemfibrozil/adverse effectsGemfibrozil/pharmacokineticsHeart Diseases/prevention & controlHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsHydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokineticsHyperlipidemias/drug therapyHypolipidemic Agents/adverse effectsHypolipidemic Agents/pharmacokineticsRhabdomyolysis/chemically inducedRhabdomyolysis/physiopathologyRisk Factors
Substances： See more » Cholinergic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsCytochrome P-450 Enzyme SystemGemfibrozil
Year: 2001 PMID： 11722675 DOI： 10.1046/j.1365-2710.2001.00369.x
Source DB: PubMed Journal: J Clin Pharm Ther ISSN： 0269-4727 Impact factor: 2.512